Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
FGL | Ann: Frugl Completes Acquisition of Trienpont | 24/04/24 | 1 | 275 | |||
|
|||||||
FGL | Ann: Results of Meeting | 18/04/24 | 2 | 509 | |||
|
|||||||
FGL | Ann: Company Secures R&D Rebate Loan Facility | 12/04/24 | 0 | 192 | |||
|
|||||||
FGL Technology | Frugl (ASX:FGL) signs bDigital deal for Southeast Asian expansion | 03/04/24 | 0 | 289 | |||
|
|||||||
FGL | Ann: Investor Presentation April 2024 | 02/04/24 | 2 | 800 | |||
|
|||||||
FGL | Ann: Pause in Trading | 02/04/24 | 0 | 175 | |||
|
|||||||
FGL | Ann: Notice of General Meeting/Proxy Form | 01/04/24 | 6 | 1.5K | |||
|
|||||||
FGL | Ann: Consolidation of Capital | 15/03/24 | 2 | 681 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |